Klaus Schulze‐Osthoff

机构：German Cancer Research Center, Heidelberg University, German Marine Research Consortium, University Children's Hospital Tübingen, University of Tübingen · ORCID：0000-0003-1443-2720

发表论文 486 篇 · 总被引 37703 次 · h-index 106

代表论文

• Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors (2023 · Molecular Cancer · 被引 82)
• BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis (2023 · Blood · 被引 63)
• The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma (2024 · Nature Communications · 被引 21)
• Inhibition of glutaminase-1 in DLBCL potentiates venetoclax-induced antitumor activity by promoting oxidative stress (2023 · Blood Advances · 被引 21)
• Limitations of Guideline‐Recommended Risk Stratification in Identifying MASLD Patients for Novel Drug Treatments (2025 · Liver International · 被引 10)
• Hepatokine‐based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients (2023 · Liver International · 被引 9)